Influence of ABCB1 Gene Polymorphism on Rivaroxaban Blood Concentration and Hemorrhagic Events in Patients With Atrial Fibrillation

Background and Objectives: Genetic data on the pharmacokinetics of rivaroxaban and identification of factors that affect its biotransformation, distribution, and excretion will allow for generation of algorithms for personalized use of this drug in patients with atrial fibrillation (AF). Here we tes...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yan, Chen, Min, Chen, Hui, Wang, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079976/
https://www.ncbi.nlm.nih.gov/pubmed/33935730
http://dx.doi.org/10.3389/fphar.2021.639854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079976/
https://www.ncbi.nlm.nih.gov/pubmed/33935730
http://dx.doi.org/10.3389/fphar.2021.639854

Ejemplares similares